Skip to main content
P206: Continued clinical improvements in adults with acid sphingomyelinase deficiency after 3-5 Years of olipudase alfa treatment: Final ASCEND trial results.
3-hour genome sequencing and targeted analysis to rapidly assess genetic risk.
Prevalence estimate of sphingosine phosphate lyase insufficiency syndrome in worldwide and select populations.